2-Deoxy-D-glucose is an anti-metabolite of D-glucose. It has the effects of interfering with the synthesis of virus-specific glycoproteins, inhibiting the proliferation of herpes simplex virus, RAN and DNA enveloped viruses, and cancer cells. At present, antiviral and anticancer drugs prepared from 2-deoxy-D-glucose have been clinically used in the treatment of herpes simplex virus and cancer, and medical health products and anti-aging cosmetics prepared from 2-deoxy-D-glucose have also been launched on the market. 2-Deoxy-D-glucose has no toxic side effects and is widely used in medical health products, anti-aging cosmetics and life science research. It has huge market potential and good development prospects.

CHEMICAL PROPERTIES

SAFETY INFORMATION

PRODUCT USAGE

2-Deoxy-D-glucose (2-DG) is a glucose molecule in which the 2-hydroxyl group is replaced by hydrogen, acting as a potent glycolytic inhibitor. Its primary application is in biomedical research and drug development, where it is used to study cellular metabolism and explore anti-tumor strategies by starving cancer cells of energy. In the pharmaceutical sector, it has gained significant attention as an antiviral agent, specifically for its potential to interfere with viral replication. Additionally, it is an essential diagnostic tool in medical imaging, serving as a precursor or analog in PET scans to identify areas of high glucose consumption. Beyond clinical use, 2-DG is utilized in biotechnology as a selection agent in yeast and fungal genetics and as a stabilizer in specialized biochemical formulations.